a State Key Laboratory of Reproductive Medicine, Institute of Toxicology, School of Public Health, Nanjing Medical University , Nanjing , China.
c Department of Pediatric Surgery , Children's Hospital of Nanjing Medical University , Nanjing , China.
Cell Cycle. 2018;17(4):459-467. doi: 10.1080/15384101.2017.1403688. Epub 2018 Feb 12.
Recently studies reported that long non-coding RNAs (lncRNAs) may take part in a lot of congenital diseases, meanwhile, Hirschsprung's disease (HSCR) is a major congenital digestive tract malformation. Nevertheless whether lncRNAs participate in the occurrence of HSCR and how it contributes to this disease are still unknown. LOC100507600 was selected from our gene expression microarray data obtained from bowel tissues from HSCR patients and negative controls. Subsequently, we used qRT-PCR to prove the result in 64 pairs of HSCR disease bowel stenosis tissues and negative controls. Transwell assay, CCK-8 assay and flow cytometry were employed to explore whether cellular functions change after knocking down the LOC100507600 in SH-SY5Y cell and human 293T cell. Dual-luciferase reporter assay was used to confirm the competitive relationship between BMI1 and LOC100507600 through their association with hsa-miR128-1-3p. Protein extraction and Western blotting were used to further confirm the relationship between LOC100507600 and BMI1. We found that LOC100507600 was obvious reduced in tissues from HSCR patients with noteworthy correlation with BMI1. Furthermore, Downregulation of LOC100507600 repressed cell migration and proliferation and didn't affect cell apoptosis or cycle. Dual-luciferase reporter assay, qRT-PCR and Western blotting assay verified that LOC100507600 serves as a competitive endogenous RNA of miR128-1-3p and down-regulates BMI1 expression by sponging miR128-1-3p in HSCR. In sum, our study researches the potential diagnostic value of LOC100507600 in HSCR and deduces that LOC100507600 can contributes to HSCR as a competitive endogenous RNA to regulate BMI1 expression by sponging miR128-1-3p.
最近的研究报道表明,长非编码 RNA(lncRNA)可能参与许多先天性疾病,同时,先天性巨结肠(HSCR)是一种主要的先天性消化道畸形。然而,lncRNA 是否参与 HSCR 的发生以及它如何导致这种疾病尚不清楚。LOC100507600 是从我们从 HSCR 患者和阴性对照的肠组织中获得的基因表达微阵列数据中选择的。随后,我们使用 qRT-PCR 在 64 对 HSCR 疾病肠狭窄组织和阴性对照中验证了这一结果。Transwell 测定、CCK-8 测定和流式细胞术用于探索在 SH-SY5Y 细胞和人 293T 细胞中敲低 LOC100507600 后细胞功能是否发生变化。双荧光素酶报告基因检测用于通过其与 hsa-miR128-1-3p 的关联来证实 BMI1 和 LOC100507600 之间的竞争关系。蛋白提取和 Western blot 进一步证实了 LOC100507600 与 BMI1 之间的关系。我们发现 LOC100507600 在 HSCR 患者的组织中明显减少,与 BMI1 有显著相关性。此外,下调 LOC100507600 抑制细胞迁移和增殖,而不影响细胞凋亡或周期。双荧光素酶报告基因检测、qRT-PCR 和 Western blot 检测证实 LOC100507600 是 miR128-1-3p 的竞争性内源性 RNA,并通过海绵吸附 miR128-1-3p 下调 HSCR 中的 BMI1 表达。总之,我们的研究研究了 LOC100507600 在 HSCR 中的潜在诊断价值,并推断 LOC100507600 可以作为一种竞争性内源性 RNA 通过海绵吸附 miR128-1-3p 来调节 BMI1 表达,从而有助于 HSCR 的发生。